Value of Echocardiographic Evaluation of Myocardial Performance Index in Predicting Major Adverse Cardiovascular Events Within 1 Year after Percutaneous Coronary Intervention in Patients with Coronary Heart Disease
DOI:
https://doi.org/10.59958/hsf.7493Keywords:
adverse cardiovascular event, coronary heart disease, echocardiography, myocardial performance index, percutaneous coronary interventionAbstract
Objective: This study aimed to evaluate the predictive efficacy of the echocardiography-derived Tei index for the occurrence of major adverse cardiovascular events (MACE) within 1 year post-percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD). Methods: A total of 98 patients diagnosed with CHD and admitted to our hospital between January 2021 and May 2023 were retrospectively selected for this study, and the two groups were divided into good prognosis group (n = 67) and poor prognosis group (n = 31) according to whether cardiovascular adverse events occurred within 1 year after PCI. Univariate and multivariate logistic regression analyses were conducted to identify the influencing factors of adverse cardiovascular events in patients with CHD following PCI, and receiver operating characteristic (ROC) analysis was employed to evaluate the efficacy of myocardial performance index measured by echocardiography in predicting adverse cardiovascular events within 1 year post-PCI in patients with CHD. The inflammatory factors of patients with different Tei indices were compared before and 24 h after PCI. Results: The differences in general data, including preoperative Tei index, left anterior descending (LAD) level, left ventricular diameter in diastole (LVDd) level, and the number of cases with left ventricular outflow tract obstruction, were not statistically significant between two groups (p > 0.05). Left ventricular ejection fraction (LVEF), maximum left ventricular thickness, postoperative Tei index, plaque score, and carotid intima–media thickness (IMT) showed statistically significant differences (p < 0.05). The findings from logistic regression analysis, considering multiple factors, indicated that Tei index, plaque score, and carotid IMT were independent predictors for adverse cardiovascular events following PCI in patients with CHD (p < 0.05). ROC analysis demonstrated an impressive area under the curve of 0.967 for echocardiographic assessment of myocardial performance index as a predictor for adverse cardiovascular events within 1 year after PCI in patients with CHD. The standard error was 0.017, 95% confidence interval was 0.935–0.999, optimal cut-off value was 0.88, sensitivity was 95.0%, and specificity was 93.3%. The comparison of inflammatory factors among patients with different Tei index values before PCI did not yield any statistically significant differences (p > 0.05), and the comparison of inflammatory factors in patients with different Tei index 24 h after PCI. The levels of inflammatory cytokines in patients with Tei ≤0.5 were lower than those in patients with Tei >0.5 (p < 0.05). Conclusion: Evaluating the myocardial performance index through echocardiography holds considerable value in predicting MACE within one year following PCI in patients diagnosed with CHD.
References
Sulava EF, Johnson JC. Management of Coronary Artery Disease. The Surgical Clinics of North America. 2022; 102: 449–464.
Duggan JP, Peters AS, Trachiotis GD, Antevil JL. Epidemiology of Coronary Artery Disease. The Surgical Clinics of North America. 2022; 102: 499–516.
Nowbar AN, Howard JP, Finegold JA. 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. International Journal of Cardiology. 2014; 174: 293–298.
Jia S, Liu Y, Yuan J. Evidence in Guidelines for Treatment of Coronary Artery Disease. Advances in Experimental Medicine and Biology. 2020; 1177: 37–73.
Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. International Journal of Molecular Sciences. 2021; 22: 3850.
Jurisch D, Laufs U. Chronic coronary syndrome: New classification of stable coronary artery disease. Der Internist. 2021; 62: 47–57. (In German)
Ali ZA, Karimi Galougahi K, Maehara A, Shlofmitz RA, Fabbiocchi F, Guagliumi G, et al. Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial. EuroIntervention. 2021; 16: 1085–1091.
Doenst T, Thiele H, Haasenritter J, Wahlers T, Massberg S, Haverich A. The Treatment of Coronary Artery Disease. Deutsches Arzteblatt International. 2022; 119: 716–723.
Fearon WF, Zimmermann FM, De Bruyne B, Piroth Z, van Straten AHM, Szekely L, et al. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. The New England Journal of Medicine. 2022; 386: 128–137.
Leitman M, Balboul Y, Burgsdorf O, Tyomkin V, Fuchs S. Myocardial work index during normal dobutamine stress echocardiography. Scientific Reports. 2022; 12: 6813.
Hahn VS, Knutsdottir H, Luo X, Bedi K, Margulies KB, Haldar SM, et al. Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction. Circulation. 2021; 143: 120–134.
Ardahanli I, Akhan O, Sahin E, Akgun O, Gurbanov R. Myocardial performance index increases at long-term follow-up in patients with mild to moderate COVID-19. Echocardiography. 2022; 39: 620–625.
Kaplangoray M, Aydın C, Toprak K, Cekici Y. Selvester score and myocardial performance index in acute anterior myocardial infarction. Revista Da Associacao Medica Brasileira (1992). 2023; 69: 325–329.
Askin L, Yuce Eİ, Tanriverdi O. Myocardial performance index and cardiovascular diseases. Echocardiography. 2023; 40: 720–725.
Sillesen H, Fuster V. Predicting coronary heart disease: from Framingham Risk Score to ultrasound bioimaging. The Mount Sinai Journal of Medicine, New York. 2012; 79: 654–663.
Correale M, Totaro A, Ieva R, Brunetti ND, Di Biase M. Time intervals and myocardial performance index by tissue Doppler imaging. Internal and Emergency Medicine. 2011; 6: 393–402.
Murai T, van de Hoef TP, van den Boogert TPW, Wijntjens GWM, Stegehuis VE, Echavarria-Pinto M, et al. Quantification of Myocardial Mass Subtended by a Coronary Stenosis Using Intracoronary Physiology. Circulation. Cardiovascular Interventions. 2019; 12: e007322.
Neumann JT, Riaz M, Bakshi A, Polekhina G, Thao LTP, Nelson MR, et al. Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older. Circulation. Genomic and Precision Medicine. 2022; 15: e003429.
Touboul PJ, Labreuche J, Vicaut E. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke, 2005; 36: 1741–1745.
Nambi V, Chambless L, Folsom AR. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. Journal of the American Heart Association. 2010; 55: 1600–1607.
Bokiniec R, Własienko P, Borszewska-Kornacka MK, Madajczak D, Szymkiewicz-Dangel J. Myocardial performance index (Tei index) in term and preterm neonates during the neonatal period. Kardiologia Polska. 2016; 74: 1002–1009.
Soliman OII, Theuns DAMJ, Ten Cate FJ, Nemes A, Caliskan K, Balk AHMM, et al. Predictors of cardiac events after cardiac resynchronization therapy with tissue Doppler-derived parameters. Journal of Cardiac Failure. 2007; 13: 805–811.
Zhang L, Xu X, Chen X, Li HS. Value of NT-proBNP and Tei index combined with GRACE score in predicting short-term prognosis of patients with emergency PCI. Hainan Medical Journal. 2015; 1569–1571, 1572. (In Chinese)
Larina VN, Bart BI, Dergunova EN, Alekhin MN. Prognostic value of the myocardial performance (Tei) index in patients with chronic heart failure. Kardiologiia. 2013; 53: 37–44. (In Russian)
Yılmaz AS, Ergül E, Çırakoğlu ÖF, Emlek N, Çetin M. Prognostic nutritional index is related to myocardial performance index in newly diagnosed nondiabetic hypertensive patients. Clinical and Experimental Hypertension. 2021; 43: 378–383.
Karabulut A, Doğan A, Tuzcu AK. Myocardial Performance Index for Patients with Overt and Subclinical Hypothyroidism. Medical Science Monitor. 2017; 23: 2519–2526.
Turfan M, Akyel A, Bolayir HA, Vatankulu MA, Aktürk M, Yetkin I, et al. Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in type 2 diabetes mellitus and impaired glucose tolerance. Kardiologia Polska. 2012; 70: 556–562.
Leonard GT, Jr, Fricker FJ, Pruett D, Harker K, Williams B, Schowengerdt KO, Jr. Increased myocardial performance index correlates with biopsy-proven rejection in pediatric heart transplant recipients. The Journal of Heart and Lung Transplantation. 2006; 25: 61–66.
